Related Experiment Video
Updated: Aug 25, 2025

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
Perioperative management of malignant hyperthermia during general anesthesia: A report of two cases
Xiaowei Chi1, Yi Xu2, Hongbing Liao1
1Department of Anesthesiology, Third People's Hospital of Chengdu Southwest Jiaotong University Chengdu China.
Abstract:
Malignant hyperthermia (MH) is a lethal complication associated with general anesthesia characterized by sudden onset, rapid progression, and high mortality. We present two seemingly typical cases of intraoperative MH development, with details on perioperative assessment and rescue. Postoperative genetic test showed mutations in the ryanodine receptor type 1 gene.
Insights
Malignant hyperthermia (MH), a severe anesthesia complication, can be managed with prompt intervention. Genetic testing identified ryanodine receptor type 1 gene mutations in patients experiencing intraoperative MH.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Medical Genetics
- Pharmacology
Background:
- Malignant hyperthermia (MH) is a life-threatening pharmacogenetic disorder triggered by volatile anesthetics and succinylcholine.
- It presents as a hypermetabolic crisis during general anesthesia, characterized by rapid onset, severe muscle rigidity, and high mortality.
- Early recognition and prompt management are critical for patient survival.
More Related Videos
Related Concept Videos
Increased Body Temperature
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Inhalational Anesthetics: Overview
Homeostatic Imbalances in Body Temperature
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Decreased Body Temperature

